Viekira Pak Approved for Hepatitis C (FREE)

By Amy Orciari Herman Edited by André Sofair, MD, MPH The FDA on Friday approved a new, all-oral, interferon-free treatment for patients with hepatitis C genotype 1, including those with cirrhosis. Viekira Pak includes a combination ombitasvir/paritaprevir/ritonavir tablet (two tablets taken once daily) plus a dasabuvir tablet …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news